Predictors of response for elagolix with add-back therapy in women with heavy menstrual bleeding associated with uterine fibroids

BACKGROUND: Uterine fibroids are one of the most common neoplasms found among women globally, with a prevalence of approximately 11 million women in the United States alone. The morbidity of this common disease is significant because it is the leading cause of hysterectomy and causes significant fun...

Descripción completa

Detalles Bibliográficos
Autores principales: Al-Hendy, Ayman, Bradley, Linda, Owens, Charlotte D., Wang, Hui, Barnhart, Kurt T., Feinberg, Eve, Schlaff, William D., Puscheck, Elizabeth E., Wang, Alice, Gillispie, Veronica, Hurtado, Sandra, Muneyyirci-Delale, Ozgul, Archer, David F., Carr, Bruce R., Simon, James A., Stewart, Elizabeth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800453/
https://www.ncbi.nlm.nih.gov/pubmed/32702363
http://dx.doi.org/10.1016/j.ajog.2020.07.032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8800453/
https://www.ncbi.nlm.nih.gov/pubmed/32702363
http://dx.doi.org/10.1016/j.ajog.2020.07.032

Ejemplares similares